The latest financial statement is for the quarter ending 2025-09-30.
| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net loss | -23,747 | -47,924 |
| Share-based compensation | 1,285 | 3,691 |
| Stock issued for services | 100 | 50 |
| Depreciation | 2,325 | 4,708 |
| Debt related fees and amortization expense | 1,061 | 3,770 |
| Intangibles and other amortization expense | 12 | 23 |
| Accretion and other expenses of series a preferred units | 2,034 | 4,311 |
| Loss (gain) on asset disposals | 4 | 0 |
| Gain on debt extinguishment | 0 | - |
| Accounts receivable | -961 | 444 |
| Inventories | -7,378 | -12,958 |
| Prepaid expenses | 95 | -274 |
| Tax credit sale receivable | 0 | -12,300 |
| Other assets | 826 | -150 |
| Accounts payable | 229 | -9,467 |
| Accrued interest expense and fees | 10,104 | 9,380 |
| Other liabilities | 2,251 | 643 |
| Net cash used in operating activities | 3,068 | -5,577 |
| Capital expenditures | 4,091 | 5,350 |
| Grant proceeds and other reimbursements received for capital expenditures | 0 | 411 |
| Net cash used in investing activities | -4,091 | -4,939 |
| Proceeds from borrowings | 7,927 | 21,319 |
| Repayments of borrowings | 10,318 | 25,411 |
| Payments on series a preferred financing | 0 | 2,200 |
| Lender debt renewal and waiver fee payments | 0 | 495 |
| Payments on finance leases | 6 | 162 |
| Proceeds from sales of common stock | 7,527 | 17,960 |
| Proceeds from exercise of stock options | 0 | 257 |
| Net cash provided by financing activities | 5,130 | 11,268 |
| Effect of exchange rate changes on cash, cash equivalents, and restricted cash | -145 | 7 |
| Net change in cash, cash equivalents, and restricted cash for period | 3,962 | 759 |
| Cash and cash equivalents at beginning of period | 3,831 | - |
| Cash and cash equivalents at end of period | 8,552 | - |
AEMETIS, INC (AMTX)
AEMETIS, INC (AMTX)